Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gini Fleming
University of Chicago Comprehensive Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Cancer Centre of Southeastern Ontario at Kingston General Hospital
Kingston, Ontario, Canada
- University Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- City of Hope Medical Center
Duarte, California, United States
- University of Southern California
Los Angeles, California, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Central Illinois Hematology Oncology Center
Springfield, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2005
- Primary completion
- 31 Jul 2010
- Completion
- 31 Jul 2010
- Last update posted
- 20 Nov 2015
- Registered enrollment
- 56
- Registry id
- NCT00238121
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.